drugset / Trial / NCT02576847

Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel

NCT02576847

Phase 3 Completed 307 enrolled Maruho Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

This study evaluates the long-term safety of once-daily application of Omiganan topical gel in subjects with severe papulopustular rosacea.

Timeline

Start
2015-10
Primary completion
2017-07-14
Completion
2018-02-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Omiganan Protein / enzyme biologic Topical

Indications